Oxford University Coronavirus Research
Why we need your help
The University of Oxford is at the forefront of global efforts to understand the coronavirus (COVID-19) and protect our communities, both in the UK and throughout the world.
Our work to date has received funding from many different sources, including the government, trusts, foundations, industry and individuals. Yet there is much still to do.
Your support today will help accelerate our time-critical research, and deliver results as quickly as possible to the people who need it most.
Over 150 senior scientists at Oxford are driving forward research across a number of key areas including:
- Drug development: Our researchers are developing new drugs to treat COVID-19, and testing existing drugs for effectiveness against the disease. We expect to see data from the first clinical trials start to inform patient treatment over the summer.
- A vaccine: Oxford’s researchers responded immediately and have developed a promising and advanced COVID-19 vaccine candidate. The vaccine is now in clinical trials in the UK. We are also working to enhance our ability to manufacture and distribute a successful vaccine at scale.
- The immune response/antibodies: We aim to define the nature of the human immune response to COVID-19 and provide evidence for therapeutic applications.
- We are working with several European governments to explore the feasibility and ethics of a coronavirus mobile app for contact tracing. If rapidly and widely deployed, our infectious disease experts believe it could significantly help to contain the spread of coronavirus.
For progress on our research, please visit our Coronavirus Research site
Spread the word
Jul 02, 2020
Jun 02, 2020